These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3009377)

  • 1. Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes.
    Yamada H; Sakamoto H; Taira M; Nishimura S; Shimosato Y; Terada M; Sugimura T
    Jpn J Cancer Res; 1986 Apr; 77(4):370-5. PubMed ID: 3009377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation.
    Yamada H; Yoshida T; Sakamoto H; Terada M; Sugimura T
    Biochem Biophys Res Commun; 1986 Oct; 140(1):167-73. PubMed ID: 3778442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
    Cui Q; Wang Z; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
    Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
    Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of oncogenes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplifications of c-erbB-1 and c-myc.
    Tadokoro K; Ueda M; Ohshima T; Fujita K; Rikimaru K; Takahashi N; Enomoto S; Tsuchida N
    Oncogene; 1989 Apr; 4(4):499-505. PubMed ID: 2654810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
    Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
    Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of ras oncogene mutation in the human tumor xenografts through serial passages.
    Kijima H; Abe Y; Yamazaki H; Ohnishi Y; Ueyama Y; Tamaoki N; Nakamura M
    Anticancer Res; 1994; 14(6B):2583-7. PubMed ID: 7872685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor.
    Hrasćan R; Pavelić K; Pavicić D; Krizanac S; Stajcer-Sittić V; Pecur L; Spaventi S; Klimpfinger M; Pavelić J
    Anticancer Res; 1996; 16(6B):3761-6. PubMed ID: 9042254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
    Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
    Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical and molecular biological aspects of stomach cancer development in human and animal].
    Khanson KP; Kalinovskiĭ VP; Novikov LB; Fedorov SN
    Vopr Med Khim; 1991; 37(6):84-8. PubMed ID: 1812623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.
    Fukumoto M; Estensen RD; Sha L; Oakley GJ; Twiggs LB; Adcock LL; Carson LF; Roninson IB
    Cancer Res; 1989 Apr; 49(7):1693-7. PubMed ID: 2647292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.
    Abbruzzese JL; Evans DB; Raijman I; Larry L; King T; Leach SD; Frazier ML
    Anticancer Res; 1997; 17(2A):795-801. PubMed ID: 9137410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of c-Ki-ras gene in human pancreatic cancer.
    Prassolov VS; Sakamoto H; Nishimura S; Terada M; Sugimura T
    Jpn J Cancer Res; 1985 Sep; 76(9):792-5. PubMed ID: 3932275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance.
    Schleger C; Verbeke C; Hildenbrand R; Zentgraf H; Bleyl U
    Mod Pathol; 2002 Apr; 15(4):462-9. PubMed ID: 11950922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma].
    Li DC
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):30-2. PubMed ID: 1396043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
    Radinsky R; Kraemer PM; Proffitt MR; Culp LA
    Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.